FindTrial
Sign In

A Study on Extrapyramidal Symptoms Caused by Antipsychotic Medications

A Study on Factors Associated with Extrapyramidal Symptoms Induced by Antipsychotic Medications - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/071966
Enrollment
287
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F068- Other specified mental disorders due to known physiological condition

Interventions

Control Intervention1: NIL: NIL

Sponsors

Rakshith A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inpatients and outpatients of either gender, aged above 18 years, undergoing treatment with at least one antipsychotic medications for not less than 1 months.

Exclusion criteria

Exclusion criteria: Patients with severe illness, who cannot communicate or co-operate. Patients with any underlining disease condition which can cause extrapyramidal symptoms. Patients who have history of alcohol and substance abuse in the last 6 months. Patients who do not wish to take part in the study.

Design outcomes

Primary

MeasureTime frame
Determination of the proportion of extrapyramidal symptoms among patients undergoing treatment with antipsychotics medications.Timepoint: 8 months—

Secondary

MeasureTime frame
Identifying the factors associated with the extrapyramidal symptoms among the patients treated with the antipsychotics medications.Timepoint: 8 months—

Countries

India

Contacts

Public ContactDr Shishir Kumar

NGSM Institute of Pharmaceutical Sciences

nandakumarvtkv@gmail.com9633023062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026